S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators

Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Berking C, Garbe C (2020)

Publication Type: Journal article

Publication year: 2020

Journal

Book Volume: 18

Pages Range: 275-294

Journal Issue: 3

DOI: 10.1111/ddg.14048

Abstract

Actinic keratoses (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline “actinic keratosis and cutaneous squamous cell carcinoma” was developed using the highest level of methodology (S3) according to regulations issued by the Association of Scientific Medical Societies in Germany (AWMF). The guideline is aimed at dermatologists, general practitioners, ENT specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings as well as other medical specialties involved in the diagnosis and treatment of patients with AK and cSCC. The guideline is also aimed at affected patients, their relatives, policy makers and insurance funds. In the first part, we will address aspects relating to diagnosis, interventions for AK, care structures and quality-of-care indicators.

Authors with CRIS profile

Involved external institutions

Vivantes - Netzwerk für Gesundheit GmbH Germany (DE) Klinikum Osnabrück Germany (DE) Eberhard Karls Universität Tübingen Germany (DE) Klinikum der Stadt Ludwigshafen am Rhein gGmbH Germany (DE) Charité - Universitätsmedizin Berlin Germany (DE) Ruhr-Universität Bochum (RUB) Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden Germany (DE) Klinikum der Universität München Germany (DE) Universitätsklinikum Regensburg Germany (DE) Universität Witten/Herdecke Germany (DE) Robert Koch-Institut (RKI) Germany (DE) Klinikum Dortmund Germany (DE) Universität Osnabrück Germany (DE) Behandlungszentrum Knappschaftskrankenhaus Recklinghausen Germany (DE) Deutsche Krebsgesellschaft (DKG) Germany (DE) Dermpath München Germany (DE) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF) e.V. Germany (DE) Universität Augsburg Germany (DE) Universitätsklinikum Tübingen Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School Germany (DE)

How to cite

APA:

Heppt, M.V., Leiter, U., Steeb, T., Amaral, T., Bauer, A., Becker, J.C.,... Garbe, C. (2020). S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators. Journal der Deutschen Dermatologischen Gesellschaft, 18(3), 275-294. https://doi.org/10.1111/ddg.14048

MLA:

Heppt, Markus V., et al. "S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators." Journal der Deutschen Dermatologischen Gesellschaft 18.3 (2020): 275-294.

BibTeX: Download